Form 4: Protagenic Therapeutics, Inc.new Executive Buys Shares
Insider Transaction (Form 4)
Garo H Armen, EXEC. CHAIR & PRINCIPAL OFF and a Director of Protagenic Therapeutics, Inc.new, purchased 2,220 shares of common stock on August 11, 2026 for $0.32 per share.
Summary
- Open-market purchase: acquired 2,220 COMMON STOCK at $0.32 ($710) on August 11, 2026; holds 34,199 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $710, committing personal capital to the stock.
Insider Transactions
Garo H Armen — Director, Officer (EXEC. CHAIR & PRINCIPAL OFF)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Open-market purchase | COMMON STOCK | 2,220 | $0 | $710 | 34,199 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Open-market purchase (2,220 shares) |
Keywords
insider transaction, Form 4, PTIX, Protagenic Therapeutics, Inc.\new, bullish, Garo H Armen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.